Abstract
The activities of 3-phosphoglycerate dehydrogenase, an enzyme of serine biosynthesis, and serine hydroxymethyltransferase, serine dehydratase and serine aminotransferase, which are competing enzymes of serine utilization, were assayed in human colon carcinomas from patients and in transplantable rat sarcomas. Serine dehydratase and serine aminotransferase activities were absent, whereas 3-phosphoglycerate dehydrogenase and serine hydroxymethyltransferase activities were markedly increased in both tumour types. Serine hydroxymethyltransferase catalyses the formation of glycine and methylene tetrahydrofolate which are important precursors for nucleotide biosynthesis. The observed enzymic imbalance in these tumours ensures that an increased capacity for the synthesis of serine is coupled to its utilisation for nucleotide biosynthesis as a part of the biochemical commitment to cellular replication in cancer cells. That this pattern is found in sarcomas and carcinomas, and in tumours of human and rodent origin, signifies its universal importance for the biochemistry of the cancer cell and singles it out as a potential target site for anti-cancer chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snell, K., Natsumeda, Y., Eble, J. et al. Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma. Br J Cancer 57, 87–90 (1988). https://doi.org/10.1038/bjc.1988.15
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.15
This article is cited by
-
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies
Frontiers of Medicine (2023)
-
ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway
Acta Pharmacologica Sinica (2022)
-
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment
Cellular Oncology (2021)
-
Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine
Nature Metabolism (2020)
-
Serine and one-carbon metabolism in cancer
Nature Reviews Cancer (2016)